Details of proposed European PFAS ban released Today, the European Chemicals Agency (ECHA) published details of a proposed ban on the production, use, sale and import of some 10,000 per- and polyfluoroalkyl substances (PFAS).
Proposed European PFAS ban officially submitted The Netherlands, Germany, Denmark, Sweden and Norway today took the first formal step towards a European ban on per- and polyfluoroalkyl substances (PFAS) by jointly submitting a restriction proposal to the European Chemicals Agency (ECHA).
More than two million invitations to get vaccinated against HPV in 2023 In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.
Annual report ‘Tuberculosis in the Netherlands’ for 2021: slight increase in number of TB patients In 2021, the number of tuberculosis (TB) patients in the Netherlands rose slightly compared to the preceding year: up to 680 TB patients from 622 in 2020. However, the 2021 number was lower than the number for 2019 (754 patients).
Sustained avian flu outbreak is the most remarkable outbreak in 2021 discussed in Zoonoses Report The outbreak of the H5N1 variant of avian flu was the most remarkable outbreak in 2021. In October of that year, the Netherlands experienced the start of the biggest outbreak of avian flu since 2003.
PFAS levels in drinking water from river water need to be brought down The National Institute for Public Health and the Environment (RIVM) advises to reduce PFAS concentrations in the drinking water in parts of the Netherlands in the coming years. This concerns drinking water produced from river water.
Almost half of 9 and 10-year-olds get HPV vaccination at first opportunity This spring, more than 800,000 young people received an invitation to be vaccinated against HPV, the human papillomavirus.
Number of tuberculosis patients in the Netherlands increased slightly in 2021 compared to 2020 The number of people with tuberculosis (TB) in the Netherlands increased slightly in 2021, reaching 680. This figure is 9% higher than it was in 2020 (622 patients).
RIVM expands HPV vaccination programme: girls and boys protected from six types of cancer with one vaccine Now not only girls, but also boys will have the opportunity to protect themselves from cancer caused by HPV.
RIVM to play greater role in tuberculosis control The Committee for Practical Tuberculosis Control (CPT) will be transferred per 1 January 2022 to the National Institute for Public Health and the Environment (RIVM) after a period of 70 years with KNCV Tuberculosis Foundation.